AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edatrust 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Ariaan Pharma

Salt Composition

Edaravone (1.5mg)

Overview Edatrust 1.5mg Injection

In amyotrophic lateral sclerosis (ALS), a debilitating neurological condition causing muscle weakness and functional impairment, Edatrust 1.5mg Injection offers therapeutic benefit. This antioxidant medication mitigates nerve cell deterioration, potentially slowing disease advancement. Administered intravenously by a qualified healthcare provider—only when oral intake is infeasible—the prescribed dosage and regimen must be strictly followed. Missed doses should be taken promptly upon recollection. Commonly reported side effects include headache, ecchymosis, and gait abnormalities. Transient injection site reactions (pain, erythema, edema) may occur but typically resolve spontaneously. Persistent or bothersome side effects warrant immediate medical consultation. Seek immediate medical attention for any allergic response, such as pruritus, or swelling of the face, lips, or tongue.

Primary Ingredients of Edatrust 1.5mg Injection

No text provided. Please provide the text you would like me to rewrite.

Uses of Edatrust 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edatrust 1.5mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Edatrust 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edatrust 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Edatrust 1.5mg Injection works:

Edatrust 1.5mg Injection functions as a neuroprotective antioxidant, enhancing cognitive function and safeguarding nerve cells. Its mechanism involves mitigating free radical-induced nerve damage, thereby slowing the advancement of amyotrophic lateral sclerosis (ALS) symptoms. This effect is achieved by restoring equilibrium between antioxidants and free radicals, reducing oxidative stress within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edatrust 1.5mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Edatrust 1.5mg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Edatrust 1.5mg Injection use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Edatrust 1.5mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Edatrust 1.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCAUTION

The 1.5mg Edatrust Injection requires careful administration to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Data on Edatrust 1.5mg Injection use in such patients is limited. Dosage alteration isn't advised for those with mild or moderate liver dysfunction.

What if you forget to take Edatrust 1.5mg Injection :

NA

Facts to Know About Edatrust 1.5mg Injection

LabelValue
Type of Compound Pyrazolone-based compounds
Potential for Dependence None.
Type of Medication Nervous system medications.
Mechanism of Action Cognitive enhancer

FAQs on Edatrust 1.5mg Injection

Edatrust 1.5mg Injection may cause side effects such as disorientation, headache, and gait disturbances. Less frequent adverse reactions include skin reactions (rash and pruritus), respiratory distress (dyspnea, chest constriction, wheezing, cough), particularly in asthmatics, and mycoses.
Edatrust 1.5mg Injection, administered intravenously as a solution, requires 60 minutes for delivery by a healthcare provider within a clinical setting. For the initial 28-day treatment cycle, daily injections are typically administered for the first 14 days. Subsequent cycles involve daily injections for the first 10 days of each 28-day period. Dosage frequency adjustments for Edatrust 1.5mg Injection are determined by the physician based on individual patient response.
Riluzole 1.5mg injection is indicated for the management of amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease characterized by the gradual deterioration of motor neurons, leading to muscle atrophy and weakness. Riluzole 1.5mg injection exerts its therapeutic effect by decelerating the neuronal damage contributing to ALS symptom progression.
Consult your physician or pharmacist regarding any allergies to edaravone, other drugs, sodium bisulfite, or Edatrust 1.5mg Injection components. Disclose all current and planned medications, vitamins, and supplements to your doctor. Dosage adjustments or close monitoring for adverse reactions may be necessary. Report any history of asthma, current pregnancy or plans for pregnancy, or breastfeeding to your doctor. Contact your doctor immediately if you conceive while undergoing edaravone treatment.
Research has yet to determine whether ALS is preventable. Nevertheless, understanding associated risk factors may lessen the likelihood of developing the condition. These factors encompass tobacco use and contact with pesticides and insecticides. Furthermore, evidence indicates a heightened ALS risk among military veterans.
Individuals of Caucasian and non-Hispanic descent exhibit the highest incidence of this disease. Between 5% and 10% of all cases have a hereditary basis, resulting from parental inheritance. Onset can occur at any age, though symptoms typically appear between 55 and 75 years of age. A slightly higher prevalence is observed in men compared to women; however, this disparity diminishes with increasing age. Research indicates a potential increased risk, approximately 1.5 to 2 times higher, among military veterans, possibly linked to wartime toxin exposure.
Studies propose a link between exposure to wartime toxins or intense physical exertion and a heightened ALS risk among veterans and athletes.
Initial ALS manifestations can involve muscle fasciculations in the limbs or tongue, muscle spasms, muscle rigidity (spasticity), and weakening of muscles in the extremities, neck, or diaphragm. Speech may become indistinct or nasal, and chewing or swallowing may become challenging. Many first notice difficulties with fine motor skills, such as fastening buttons, writing, or using keys, starting in the hand or arm. Alternatively, leg weakness may be the primary symptom, presenting as gait difficulties, increased tripping, or stumbling.
Edatrust 1.5mg Injection
517
MRP 630
17% off